Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM4 | O15151 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | CASP3 | P42574 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.47 |
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.45 |
| ▸ | FDFT1 | P37268 | 1/20 | 0.45 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391787 | 0.96 | MDM4 (0.51) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL30096349 | 0.91 | CASP3 (0.54) | MDM4TP53CASP3KMT2APTPN1 | |
| SCHEMBL29774265 | 0.89 | PTPN1 (0.54) | MDM4TP53PTPN1 | |
| SCHEMBL29908070 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL2309917 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL119442 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL29401991 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL119451 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL29370319 | 0.89 | MDM4 (0.58) | MDM4TP53CASP3KMT2ASLC17A5 | |
| SCHEMBL31398357 | 0.89 | MDM4 (0.60) | MDM4TP53CASP3KMT2ASLC17A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114685614-B | Solid-phase synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-115038711-B | Synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115461355-A | Method for preparing atosiban | 厦门胜泽泰医药科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115038711-A | Synthetic method of atosiban | 湖北健翔生物制药有限公司 | 2022-09-09 | — | — | CN | disclosed |
| CN-114685614-A | Solid-phase synthesis method of atosiban | 湖北健翔生物制药有限公司 | 2022-07-01 | — | — | CN | disclosed |